NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,239 filers reported holding NOVARTIS A G in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,132,564 | +6.9% | 38,818 | -2.9% | 0.57% | +7.6% |
Q1 2024 | $3,866,260 | -5.6% | 39,970 | -1.5% | 0.53% | -8.2% |
Q4 2023 | $4,095,203 | -3.9% | 40,559 | -3.1% | 0.58% | -14.6% |
Q3 2023 | $4,262,190 | -1.1% | 41,844 | -2.0% | 0.67% | +42.6% |
Q2 2023 | $4,308,212 | +7.2% | 42,694 | -2.3% | 0.47% | -12.1% |
Q1 2023 | $4,020,548 | +1.3% | 43,702 | -0.1% | 0.54% | -1.6% |
Q4 2022 | $3,967,238 | +17.9% | 43,731 | -1.2% | 0.55% | +1.7% |
Q3 2022 | $3,364,000 | -11.9% | 44,252 | -2.0% | 0.54% | -0.2% |
Q2 2022 | $3,817,000 | -2.3% | 45,152 | +1.5% | 0.54% | +10.7% |
Q1 2022 | $3,905,000 | -6.1% | 44,502 | -6.4% | 0.49% | -13.7% |
Q4 2021 | $4,157,000 | -1.6% | 47,525 | -8.0% | 0.56% | -6.6% |
Q3 2021 | $4,226,000 | -10.7% | 51,674 | -0.4% | 0.60% | -8.5% |
Q2 2021 | $4,734,000 | +1.4% | 51,889 | -5.0% | 0.66% | -10.6% |
Q1 2021 | $4,669,000 | -13.9% | 54,619 | -4.9% | 0.74% | -21.8% |
Q4 2020 | $5,423,000 | +0.3% | 57,432 | -7.7% | 0.94% | -14.8% |
Q3 2020 | $5,409,000 | -4.6% | 62,201 | -4.2% | 1.11% | -11.7% |
Q2 2020 | $5,672,000 | +3.3% | 64,938 | -2.5% | 1.25% | +1.4% |
Q1 2020 | $5,492,000 | -18.6% | 66,613 | -6.5% | 1.24% | +11.6% |
Q4 2019 | $6,743,000 | +5.1% | 71,216 | -3.6% | 1.11% | -11.3% |
Q3 2019 | $6,417,000 | -9.2% | 73,841 | -4.6% | 1.25% | -10.8% |
Q2 2019 | $7,067,000 | -11.1% | 77,395 | -6.4% | 1.40% | +124.6% |
Q1 2019 | $7,952,000 | +9.2% | 82,709 | -2.5% | 0.62% | -50.8% |
Q4 2018 | $7,281,000 | -32.6% | 84,855 | -32.3% | 1.27% | -32.2% |
Q3 2018 | $10,804,000 | +12.7% | 125,390 | -1.2% | 1.87% | +2.5% |
Q2 2018 | $9,590,000 | -8.3% | 126,951 | -1.8% | 1.82% | -4.2% |
Q1 2018 | $10,455,000 | -6.9% | 129,315 | -3.3% | 1.90% | -7.2% |
Q4 2017 | $11,224,000 | -5.4% | 133,680 | -3.3% | 2.05% | -7.6% |
Q3 2017 | $11,866,000 | +1.5% | 138,221 | -1.3% | 2.22% | +20.4% |
Q2 2017 | $11,688,000 | +12.0% | 140,024 | -0.4% | 1.84% | -9.8% |
Q1 2017 | $10,436,000 | +1.0% | 140,516 | -1.0% | 2.04% | +121.8% |
Q4 2016 | $10,335,000 | -7.6% | 141,885 | +0.2% | 0.92% | -51.8% |
Q3 2016 | $11,183,000 | -6.7% | 141,635 | -2.5% | 1.91% | -27.4% |
Q2 2016 | $11,988,000 | +10.8% | 145,295 | -2.8% | 2.63% | +4.6% |
Q1 2016 | $10,824,000 | -18.8% | 149,427 | -3.6% | 2.52% | -16.9% |
Q4 2015 | $13,330,000 | -10.0% | 154,928 | -3.8% | 3.03% | -10.4% |
Q3 2015 | $14,811,000 | -16.6% | 161,128 | -10.8% | 3.38% | -1.7% |
Q2 2015 | $17,756,000 | -3.4% | 180,555 | -3.2% | 3.44% | +0.5% |
Q1 2015 | $18,389,000 | -20.5% | 186,478 | -25.3% | 3.42% | +0.7% |
Q4 2014 | $23,132,000 | -52.5% | 249,647 | -51.8% | 3.40% | -17.8% |
Q3 2014 | $48,742,000 | -0.3% | 517,814 | -4.1% | 4.14% | +7.6% |
Q2 2014 | $48,870,000 | +2.5% | 539,830 | -3.7% | 3.85% | -1.0% |
Q1 2014 | $47,662,000 | -6.1% | 560,600 | -11.2% | 3.88% | -1.5% |
Q4 2013 | $50,738,000 | +4.3% | 631,230 | -0.5% | 3.94% | +2.2% |
Q3 2013 | $48,648,000 | -0.0% | 634,172 | -7.8% | 3.86% | -6.7% |
Q2 2013 | $48,650,000 | +93.0% | 688,022 | +94.4% | 4.14% | -5.7% |
Q1 2013 | $25,213,000 | – | 353,916 | – | 4.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |